June 25, 2008
BSD-2000 Cancer Treatment System By BSD Medical Installed in Prestigious Liaocheng Peoples Hospital in China
BSD Medical Corp. (NASDAQ:BSDM) today announced that another BSD-2000 hyperthermia system has been purchased, installed and is now in use in China, at the Liaocheng Peoples Hospital located in Liaocheng City, in the Western Shandong Province of the People's Republic of China. The Liaocheng Peoples Hospital has recently added a 19-floor, state-of-the-art building equipped with the most up-to-date cancer imaging and therapy devices in the world. This hospital serves as the main cancer center to this city of over 5.5 million people. The hospital has offered less sophisticated forms of hyperthermia therapy used for treating superficial cancers only, and is enthusiastic about the addition of the advanced capabilities of the BSD-2000 to treat deep cancers as part of its cancer arsenal.
BSD Medical is pleased with the addition of the Liaocheng Peoples Hospital as a center of excellence in China and as a candidate for participating in future high-level international clinical studies. The hospital has recently received certification from the governing hospital group in China permitting it to participate in key clinical trials. With over 2,000 beds, the Liaocheng Peoples Hospital treats large numbers of patients.
BSD Medical Corp. is the leading developer of systems used to deliver hyperthermia therapy for the treatment of cancer. Hyperthermia therapy is used to kill cancer directly and increase the effectiveness of companion radiation treatments for certain tumors. For further information visit BSD Medical's website at www.BSDMedical.com or BSD's patient website at www.treatwithheat.com.
Statements contained in this press release that are not historical facts are forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. All forward-looking statements are subject to risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date on which such statements are made, and the Company undertakes no obligation to update such statements to reflect events or circumstances arising after such date.